Scarica l'app Stockscreener
1.72
2.40%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.67
Aprire:
$1.73
Volume 24 ore:
149.70K
Relative Volume:
0.58
Capitalizzazione di mercato:
$3.32M
Reddito:
-
Utile/perdita netta:
$-25.56M
Rapporto P/E:
-0.3308
EPS:
-5.2
Flusso di cassa netto:
$-19.35M
1 W Prestazione:
-56.27%
1M Prestazione:
-76.05%
6M Prestazione:
-3.39%
1 anno Prestazione:
-22.62%
Intervallo 1D:
$1.68
$1.81
Intervallo di 1 settimana:
$1.52
$3.98
Portata 52W:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Confronta BIVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.71 | 3.32M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.12 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.50 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.02 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.90 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
303.40 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
BioVie Completes $10.4 Million Public Offering - TipRanks
BioVie closes $12 million public offering of units - Investing.com
BioVie Inc. Announces Closing of $12 Million Public Offering - GlobeNewswire
BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline - Stock Titan
Bloomberg to Air New to The Street Episode #683 Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - AInvest
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - ACCESS Newswire
BioVie stock dips on pricing $12M securities offering - MSN
BioVie Raises $12mln, Sees Upside to $55.00, Analysts Call it an "Outperform" Investment Opportunity - AInvest
BioVie Prices 6M Share Secondary at $2.00, Below Last Closing Price of $2.91 - AInvest
BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewswire
BioVie (BIVI.O) Crashes 42.78%: What's Behind the Sharp Intraday Move? - AInvest
Biovie stock plunges after pricing $12 million public offering By Investing.com - Investing.com Canada
Biovie stock plunges after pricing $12 million public offering - Investing.com
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results - Benzinga
BioVie's 45% Plunge: A Capital Raise Gone Wrong? - AInvest
Dow Surges 300 Points; American Axle & Manufacturing Posts Upbeat Earnings - Benzinga
BioVie Announces $12M Securities Offering - AInvest
BioVie's (BIVI) 43% Plunge: A Volatile Turn in the Biotech Arena? - AInvest
BioVie Stock Dips After Share Offering News - timothysykes.com
Why Is BioVie Stock (BIVI) Down 50% Today? - TipRanks
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed - Stock Titan
BioVie prices $12 million public offering of units at $2.00 each - Investing.com
Biovie's $12M Equity Raise: Is This a Strategic Lifeline or a Warning Signal for Small-Cap Biotechs? - AInvest
BioVie Inc. Raises $12 Million in Public Offering - AInvest
Biovie announces pricing of $12 million public offering - MarketScreener
Biovie Announces Pricing Of $12 Million Public Offering - TradingView
BioVie Inc. Announces Pricing of $12 Million Public Offering - Benzinga
What is the risk reward ratio of investing in BioVie Inc. stockHigh-velocity gains - Jammu Links News
Is it the right time to buy BioVie Inc. stockSkyrocketing profit margins - Jammu Links News
What catalysts could drive BioVie Inc. stock higher in 2025Achieve rapid returns with smart investment plans - Jammu Links News
Does BioVie Inc. stock perform well during market downturnsExplosive capital appreciation - Jammu Links News
How strong is BioVie Inc. company’s balance sheetUnprecedented profit potential - Jammu Links News
What are BioVie Inc. company’s key revenue driversInvest confidently with professional market insights - Jammu Links News
How does BioVie Inc. compare to its industry peersFree Risk Assessment Services - Jammu Links News
What institutional investors are buying BioVie Inc. stockStay ahead with advanced stock screening tools - Jammu Links News
Is BioVie Inc. stock overvalued or undervaluedMarket-beating returns - Jammu Links News
BioVie Inc. Stock Analysis and ForecastUnstoppable profit momentum - Jammu Links News
Should I hold or sell BioVie Inc. stock in 2025Free Stock Market Query - Jammu Links News
Why is BioVie Inc. stock attracting strong analyst attentionExplosive portfolio gains - Jammu Links News
When is BioVie Inc. stock expected to show significant growthUnlock expert insights for smarter investing - Jammu Links News
What makes BioVie Inc. stock price move sharplyOutstanding stock performance - Jammu Links News
What are the latest earnings results for BioVie Inc.Chart Pattern Forecasts For Consistent Profits - Jammu Links News
Why BioVie Inc. stock attracts strong analyst attentionValue Driven Trading Forecast Analysis - beatles.ru
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):